Who owns AKARI THERAPEUTICS PLC SPONSORED?

Tip: Access positions for across all investors

Analyze quarterly positions in Akari Therapeutics Plc Sponsored with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Akari Therapeutics Plc Sponsored stock

Who bought or sold AKARI THERAPEUTICS PLC SPONSORED this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Cresset Asset Management 823k $238k 0% Dec 2025
 View chart
Warberg Asset Management 308k $89k 100% Dec 2025
 View chart
Palo Alto Investors 146k $148k 0% Sep 2025
 View chart
HighTower Advisors 79k $23k 0% Dec 2025
 View chart
Jane Street 72k $21k 100% Dec 2025
 View chart
CWA Asset Management 55k $16k 100% Dec 2025
 View chart
XTX Topco 49k $14k 100% Dec 2025
 View chart
UBS Group 33k $9.5k 54658% Dec 2025
 View chart
HPM Partners 24k $6.8k 0% Dec 2025
 View chart
Intl Fcstone 21k $6.2k 100% Dec 2025
 View chart
Skyview Financial Group 21k $5.9k 100% Dec 2025
 View chart
Independent Advisor Alliance 17k $4.9k 57% Dec 2025
 View chart
Goss Wealth Management 6.8k $2.0k 0% Dec 2025
 View chart
Accent Capital Management 5.0k $1.4k -50% Dec 2025
 View chart
SBI Securities 200.00 $58.000000 100% Dec 2025
 View chart
Truvestments Capital 50.00 $14.000000 0% Dec 2025
 View chart
Cornerstone Planning Group 5.00 $1.000000 -29% Dec 2025
 View chart

Who sold out of Akari Therapeutics Plc Sponsored?

Fund or Company Name Date Sold Shares Held Valued At
Omnia Family Wealth Sep 2025 28k $29k
Virtu Financial Sep 2025 23k $22k
Two Sigma Securities Sep 2025 20k $20k
EverSource Wealth Advisors Sep 2025 44.00 $44.000000